This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hatakeyama, Y.
Right arrow Articles by Shum, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hatakeyama, Y.
Right arrow Articles by Shum, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Facebook   Add to Technorati   Add to Twitter  
What's this?
The Journal of Bone and Joint Surgery (American) 85:13-18 (2003)
© 2003 The Journal of Bone and Joint Surgery, Inc.

Basic Science

Smad Signaling in Mesenchymal and Chondroprogenitor Cells

Yuji Hatakeyama, DDS, PhD, Jennifer Nguyen, BSc, Xibin Wang, PhD, Glen H. Nuckolls, PhD and Lillian Shum, PhD

Corresponding author: Lillian Shum, PhD
Cartilage Biology and Orthopaedics Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Department of Health and Human Services, 6 Center Drive, MSC 2745, Building 6, Room 324, Bethesda, MD 20892-2745. E-mail address: shuml{at}mail.nih.gov

In support of their research or preparation of this manuscript, one or more of the authors received grants or outside funding from National Institutes of Health Grant Z01 AR41114. None of the authors received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.

Abstract

Background: Bone morphogenetic proteins (BMPs) are pleiotropic differentiation factors that regulate cell fate determination by orchestrating the activities of downstream signal transducers. Although BMP ligands can elicit signal transduction from heterodimeric combinations of several type-I and type-II receptors, cytoplasmic transducers of the BMP signal include only three known BMP-specific regulatory Smad proteins: Smad1, 5, and 8. In order to determine the combination of signals that regulate chondrogenesis by BMPs, we analyzed the functions of BMP Smad subtypes.

Methods: Multipotential mesenchymal C3H10T1/2 cells and monopotential chondroprogenitor MC615 cells were placed in micromass culture in the presence or absence of BMP4. Chondrogenic differentiation was assayed by measuring Sox9 and type-II collagen gene expression and by alcian blue staining. Transactivation of type-II collagen by regulatory Smads singly, or in combination with Smad4, which partners with regulatory Smads, was assayed by luciferase activity.

Results: In the absence of BMP4, mesenchymal cells did not exhibit chondrogenic differentiation, whereas chondroprogenitor cells showed increased cartilage marker expression. In the presence of BMP4, the rate and extent of chondrogenesis increased in a dose-dependent manner for both cell types. We further determined that Smad1 or Smad5, but not Smad8, synergized with Smad4 in the transactivation of the type-II collagen promoter in chondroprogenitor cells. In contrast, Smad8 and Smad4 presented modest synergy in mesenchymal cells.

Conclusions: Taken together, our data suggest that uncommitted mesenchymal cells do not have the cellular competence to respond to the rate-limiting chondroinductive factor BMP. However, in chondroprogenitor cells, BMP stimulates differentiation through mechanisms mediated by Smad1 or Smad5 in combination with Smad4.

Clinical Relevance: Our functional studies of these mesenchymal and chondroprogenitor cells will establish the mechanisms of lineage commitment and provide a platform for molecular manipulations with predictable lineage outcome. Therefore, our knowledge base can provide the molecular basis for stem/progenitor cell differentiation and a paradigm for tissue engineering.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Facebook Facebook   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
E. A. Lin, L. Kong, X.-H. Bai, Y. Luan, and C.-j. Liu
miR-199a*, a Bone Morphogenic Protein 2-responsive MicroRNA, Regulates Chondrogenesis via Direct Targeting to Smad1
J. Biol. Chem., April 24, 2009; 284(17): 11326 - 11335.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
L. C. Rosenberg
Introductory Comments
J. Bone Joint Surg. Am., August 1, 2003; 85(90003): 1 - 2.
[Full Text] [PDF]